Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Svein G Dahl

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Basic & Clinical Pharmacology & Toxicology|March 1, 2005
Molecular modelling of drug targets: the past, the present and the futureSvein G Dahl, Ingebrigt Sylte
Journal of Psychopharmacology (Oxford, England)|June 21, 2006
From genomics to drug targetsSvein G Dahl, Ingebrigt Sylte
Annals of Medicine|October 10, 2002
Bioinformatics: from genome to drug targetsSvein G Dahl, Kurt Kristiansen, Ingebrigt Sylte
European Journal of Medicinal Chemistry|February 8, 2005
Atypical and typical antipsychotic drug interactions with the dopamine D2 receptorErik Hjerde, Svein G Dahl, Ingebrigt Sylte
Journal of Molecular Modeling|February 25, 2009
Structure and localisation of drug binding sites on neurotransmitter transportersAina W Ravna, Ingebrigt Sylte, Svein G Dahl
The Journal of Pharmacology and Experimental Therapeutics|August 29, 2003
Molecular mechanism of citalopram and cocaine interactions with neurotransmitter transportersAina Westrheim Ravna, Ingebrigt Sylte, Svein G Dahl
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2004
Structures and models of transporter proteinsSvein G Dahl, Ingebrigt Sylte, Aina Westrheim Ravna
Journal of Computer-Aided Molecular Design|November 26, 2003
Molecular model of the neural dopamine transporterAina Westrheim Ravna, Ingebrigt Sylte, Svein G Dahl
Bioorganic & Medicinal Chemistry|October 12, 2005
Putative drug binding conformations of monoamine transportersAina Westrheim Ravna, Ingebrigt Sylte, Kurt Kristiansen, et al.
BMC Research Notes|December 24, 2011
A short update on the structure of drug binding sites on neurotransmitter transportersMari Gabrielsen, Ingebrigt Sylte, Svein G Dahl, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Basic & Clinical Pharmacology & Toxicology|March 1, 2005
Molecular modelling of drug targets: the past, the present and the futureSvein G Dahl, Ingebrigt Sylte
Journal of Psychopharmacology (Oxford, England)|June 21, 2006
From genomics to drug targetsSvein G Dahl, Ingebrigt Sylte
Annals of Medicine|October 10, 2002
Bioinformatics: from genome to drug targetsSvein G Dahl, Kurt Kristiansen, Ingebrigt Sylte
European Journal of Medicinal Chemistry|February 8, 2005
Atypical and typical antipsychotic drug interactions with the dopamine D2 receptorErik Hjerde, Svein G Dahl, Ingebrigt Sylte
Journal of Molecular Modeling|February 25, 2009
Structure and localisation of drug binding sites on neurotransmitter transportersAina W Ravna, Ingebrigt Sylte, Svein G Dahl
The Journal of Pharmacology and Experimental Therapeutics|August 29, 2003
Molecular mechanism of citalopram and cocaine interactions with neurotransmitter transportersAina Westrheim Ravna, Ingebrigt Sylte, Svein G Dahl
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2004
Structures and models of transporter proteinsSvein G Dahl, Ingebrigt Sylte, Aina Westrheim Ravna
Journal of Computer-Aided Molecular Design|November 26, 2003
Molecular model of the neural dopamine transporterAina Westrheim Ravna, Ingebrigt Sylte, Svein G Dahl
Bioorganic & Medicinal Chemistry|October 12, 2005
Putative drug binding conformations of monoamine transportersAina Westrheim Ravna, Ingebrigt Sylte, Kurt Kristiansen, et al.
BMC Research Notes|December 24, 2011
A short update on the structure of drug binding sites on neurotransmitter transportersMari Gabrielsen, Ingebrigt Sylte, Svein G Dahl, et al.
Pageof 2